Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA Warning Letter Calls Attention to Celltrion's 'Poor' Aseptic Practices
Feb 08 2018
•
By
Joanne S. Eglovitch
Celltrion's Incheon plant • Source: Google street view
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance